{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T14:39:41Z","timestamp":1790347181309,"version":"4.1.0"},"reference-count":51,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K01 DK138273"],"award-info":[{"award-number":["K01 DK138273"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01 DK115534"],"award-info":[{"award-number":["R01 DK115534"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["dom-pubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Obesity Metabolism"],"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To characterize trends in obesity and prescriptions for glucagon\u2010like peptide\u20101 receptor agonists (GLP\u20101RAs) across body mass index (BMI) categories among US youth and adults with type 1 diabetes (T1D) from 2008 to 2023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods<\/jats:title>\n                    <jats:p>Patients with T1D were identified using a validated algorithm using de\u2010identified electronic health record (EHRs) data from 33 US health systems. BMI categories were based on age\u2010 and sex\u2010specific percentiles for youth (2\u201319\u2009years) and World Health Organization cut points for adults (\u226520\u2009years). Trends in obesity and GLP1\u2010RA prescriptions were characterized by BMI categories among youth and adults with T1D from 2008\u20132011 to 2020\u20132023.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      From 2008\u20132011 to 2020\u20132023, the prevalence of obesity among youth with T1D increased from 18.1% (95% confidence interval [CI], 17.3%\u201318.9%) to 26.0% (25.2%\u201326.8%) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2010for\u2010trend\u2009&lt;\u20090.001). Among adults with T1D, the prevalence of obesity rose from 30.5% (30.0%\u201331.0%) in 2008\u20132011 to 38.1% (37.8%\u201338.5%) in 2020\u20132023 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2010for\u2010trend\u2009&lt;\u20090.001). Obesity was highest in Black and Hispanic youth and adults, and racial and ethnic disparities persisted over time. Over the last 15\u2010year period, GLP\u20101RA prescriptions significantly increased across all BMI categories in a dose\u2013response manner among both youth and adults with T1D (all\n                      <jats:italic>p<\/jats:italic>\n                      \u2010for\u2010trend\u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Over the last 15\u2010year period, obesity has reached epidemic levels in US youth and adults with T1D, with significant disparities among racial and ethnic minoritized populations. These findings, coupled with the increase in GLP\u20101RA prescriptions, underscore the urgent need for data on GLP\u20101RAs' safety and effectiveness and guidance for obesity management in T1D.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/dom.16300","type":"journal-article","created":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T18:55:40Z","timestamp":1741632940000},"page":"2967-2976","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Trends in obesity and glucagon\u2010like peptide\u20101 receptor agonist prescriptions in type 1 diabetes in the\n                    <scp>United States<\/scp>"],"prefix":"10.1111","volume":"27","author":[{"given":"Yunwen","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Epidemiology Johns Hopkins Bloomberg School of Public Health  Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8460-1617","authenticated-orcid":false,"given":"Justin B.","family":"Echouffo Tcheugui","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes, and Metabolism Johns Hopkins School of Medicine  Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Coresh","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Johns Hopkins Bloomberg School of Public Health  Baltimore Maryland USA"},{"name":"Department of Population Health New York University Grossman School of Medicine  New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan E.","family":"Grams","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Johns Hopkins Bloomberg School of Public Health  Baltimore Maryland USA"},{"name":"Department of Population Health New York University Grossman School of Medicine  New York New York USA"},{"name":"Division of Precision Medicine, Department of Medicine New York University Grossman School of Medicine  New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6923-7151","authenticated-orcid":false,"given":"Elizabeth","family":"Selvin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Johns Hopkins Bloomberg School of Public Health  Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fang","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Johns Hopkins Bloomberg School of Public Health  Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0374-6927","authenticated-orcid":false,"given":"Jung\u2010Im","family":"Shin","sequence":"additional","affiliation":[{"name":"Department of Epidemiology Johns Hopkins Bloomberg School of Public Health  Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213\u20108587(21)00246\u20101"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hct123"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc18\u20101446"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12933\u2010021\u201001340\u20104"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.10.2871"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399\u20105448.2009.00519.x"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2015.05.046"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464\u20105491.2010.02956.x"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab927"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.7326\/M22\u20103078"},{"key":"e_1_2_9_12_1","unstructured":"FryarCD CarrollMD AffulJ.Prevalence of overweight obesity and severe obesity among children and adolescents aged 2\u201319\u2009years: United States 1963\u20131965 through 2017\u20132018. NCHS Health E\u2010Stats. September 22 2020. Accessed June 10 2024.https:\/\/www.cdc.gov\/nchs\/data\/hestat\/obesity-child-17-18\/overweight-obesity-child-H.pdf"},{"key":"e_1_2_9_13_1","unstructured":"FryarCD CarrollMD AffulJ.Prevalence of overweight obesity and severe obesity among adults aged 20 and over: United States 1960\u20131962 through 2017\u20132018. NCHS Health E\u2010Stats. 2020. Accessed June 11 2024.https:\/\/www.cdc.gov\/nchs\/data\/hestat\/obesity-adult-17-18\/overweight-obesity-adults-H.pdf"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc24\u2010S008"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.08.045"},{"key":"e_1_2_9_16_1","unstructured":"Novo Nordisk.VICTOZA (liraglutide) injection for subcutaneous use. Accessed September 24 2024.https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/022341s039lbl.pdf"},{"key":"e_1_2_9_17_1","unstructured":"Novo Nordisk.SAXENDA (liraglutide) injection for subcutaneous use. Accessed September 24 2024.https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2023\/206321s016lbl.pdf"},{"key":"e_1_2_9_18_1","unstructured":"Novo Nordisk.WEGOVY (semaglutide) injection for subcutaneous use. Accessed September 24 2024.https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/215256s011lbl.pdf"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.18581"},{"key":"e_1_2_9_20_1","unstructured":"Optum Labs.Optum Labs and Optum Labs Data Warehouse (OLDW) Descriptions and Citation; 2023. PDF. Reproduced with permission from Optum Labs."},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2014.0038"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc12\u20100964"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4377"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110859"},{"key":"e_1_2_9_25_1","unstructured":"CDC.BMI for children and teens. Centers for Disease Control and Prevention. March 21 2023. Accessed December 5 2023.https:\/\/www.cdc.gov\/obesity\/basics\/childhood-defining.html"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(03)15268\u20103"},{"key":"e_1_2_9_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.23639"},{"key":"e_1_2_9_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2017.01.012"},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41366\u2010023\u201001429\u20108"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2021.4182"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2022.100249"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurpra.2021.02.022"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jada.2006.02.002"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2018.05.011"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11845\u2010021\u201002741\u2010w"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110697"},{"key":"e_1_2_9_37_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc08\u20100720"},{"key":"e_1_2_9_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2018.05.020"},{"key":"e_1_2_9_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028198"},{"key":"e_1_2_9_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.22726"},{"key":"e_1_2_9_41_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.1831"},{"key":"e_1_2_9_42_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc16\u20100691"},{"key":"e_1_2_9_43_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc16\u20100690"},{"key":"e_1_2_9_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213\u20108587(17)30013\u2010X"},{"key":"e_1_2_9_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2032183"},{"key":"e_1_2_9_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.22794"},{"key":"e_1_2_9_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(21)01324\u20106"},{"key":"e_1_2_9_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107519"},{"key":"e_1_2_9_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2206038"},{"key":"e_1_2_9_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(23)01200\u2010X"},{"key":"e_1_2_9_51_1","unstructured":"WilliamsE RudowitzR PublishedCB.Medicaid coverage of and spending on GLP\u20101s. KFF. November 4 2024. Accessed January 6 2025.https:\/\/www.kff.org\/medicaid\/issue-brief\/medicaid-coverage-of-and-spending-on-glp-1s\/"},{"key":"e_1_2_9_52_1","unstructured":"US Food and Drug Administration.FDA approves new treatment for pediatric patients with type 2 diabetes. FDA. March 24 2020. Accessed January 17 2025.https:\/\/www.fda.gov\/news\u2010events\/press\u2010announcements\/fda\u2010approves\u2010new\u2010treatment\u2010pediatric\u2010patients\u2010type\u20102\u2010diabetes"}],"container-title":["Diabetes, Obesity and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/pdf\/10.1111\/dom.16300","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:56:36Z","timestamp":1761893796000},"score":1,"resource":{"primary":{"URL":"https:\/\/dom-pubs.pericles-prod.literatumonline.com\/doi\/10.1111\/dom.16300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1111\/dom.16300"],"URL":"https:\/\/doi.org\/10.1111\/dom.16300","archive":["Portico"],"relation":{},"ISSN":["1462-8902","1463-1326"],"issn-type":[{"value":"1462-8902","type":"print"},{"value":"1463-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]},"assertion":[{"value":"2024-11-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-03","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}